The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 22.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it buy, with a mean price target of $166.
Allegion
ALLE · a US exchange · USD · Market cap $12.9B · 13,300 employees
Allegion plc engages in the provision of security products and solutions worldwide.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Allegion holds its Markdown at $151.27. Consolidating, no directional conviction, held for 9 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 9 days |
| Price at the screen | $151.27 |
| Valuation | 19.85 trailing · 15.48 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.84 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 37.91% | Below 33% | Interest-bearing debt is 37.9% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 15.20% | Below 49% | Money owed to the company is 15.2% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.30% | Below 5% | Only 0.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 21% discount to our $182.74 fair value, moderate competitive moat, 12.70% revenue growth.
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 20.8% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +12% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsEvery secure door click hides a debt load
Think of Allegion as the quiet provider of locks and exit systems that keep offices, homes and factories safe across the Americas and beyond. The business shows solid 10% revenue growth, a 15% profit margin and 34% return on equity, with a moderate moat that supports steady demand. Yet the opportunity rating is avoid because the company fails our ethical screen on its debt ratio.
The numbers appear reasonable at a 14.3 times forward earnings multiple and a share price well below our fair value estimate. Still, high leverage crosses a line we do not accept regardless of growth or analyst targets clustered around 165 dollars. This is exactly what the screen is designed to catch.
Currency moves, construction cycles and any rise in interest costs could quickly pressure margins and cash flow. The ethical flag remains the binding constraint. Analysis, not advice.
| Forward P/E | 15.5xpriced for continued growth |
| Trailing P/E | 19.9xreasonably valued |
| EPS, trailing | 7.62 |
| EPS, forward | 9.77 |
| Revenue growth | +12.7%steady growth |
| Profit margin | 15.4%healthy profit margins |
| Return on equity | 33.7%an exceptional return on shareholder capital |
| FCF yield | 3.77% |
| Dividend yield | 158.00% |
| Debt to equity | 1.05a meaningful debt load worth watching |
| Current ratio | 1.93healthy short-term liquidity |
| Beta | 0.84steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 125.00 - 183.11 |
| Moat | MODERATE |
| Market cap | $12.9B |
| Employees | 13,300 |
The risks · The things to watch: its business and earnings are exposed to Ireland and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeALLE trades on a US exchange (the company is based in Ireland). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it buy, with a mean price target of $166.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it buy, with a mean price target of $166.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it buy, with a mean price target of $166.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | MARTENS ROBERT C | Officer | 3,993 | $547,640 | |
| 2026-03-11 | MAIN SUSAN L | Director | 2,000 | $299,215 | |
| 2026-02-19 | ECKERSLEY TIMOTHY P | Officer | 1,691 | · | |
| 2026-02-19 | KEMP TRACY L | Chief Technology Officer | 923 | · | |
| 2026-02-19 | ILARDI DAVID S. | Officer | 1,691 | · | |
| 2026-02-19 | MUSIAL NICKOLAS A. | Officer | 923 | · | |
| 2026-02-19 | WAGNES MICHAEL J. | Chief Financial Officer | 2,460 | · | |
| 2026-02-19 | HAWES -PRECZEWSKI JENNIFER L | Officer | 1,076 | · | |
| 2026-02-19 | BLASKO JOSEPH | General Counsel | 1,384 | · | |
| 2026-02-19 | WENOS VINCENT | Chief Technology Officer | 999 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 1K–15K |
| 31 Jul2026 | Dave McCormick | Republican | sell | 50K–100K |
| 31 Jul2026 | Dave McCormick | Republican | sell | 50K–100K |
| 30 Mar2026 | Alan Armstrong | Republican | buy | 1K–15K |
| 30 Jul2026 | Dave McCormick | Republican | sell | 250K–500K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $132.35 | -1.9% | · | $981 | -1.9% |
| 2 months | $144.81 | -10.3% | · | $897 | -10.3% |
| 3 months | $145.30 | -10.6% | $0.55 | $897 | -10.3% |
| 6 months | $164.09 | -20.9% | $0.55 | $795 | -20.5% |
| 1 year | $138.63 | -6.3% | $1.06 | $944 | -5.6% |
| 2 years | $114.88 | +13.0% | $3.01 | $1,157 | +15.7% |
| 3 years | $108.46 | +19.7% | $4.84 | $1,242 | +24.2% |
| 5 years | $129.86 | +0.0% | $8.01 | $1,062 | +6.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ALLE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.